Valuation Gennex Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:02:27 2026-09-25 EDT			5-day change	1st Jan Change
10.10 ^INR	-0.49%		-1.66%	-29.37%

08-14	Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-30	Gennex Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026
Market Cap ¹	494.6	952.6	1,004	3,594	2,741	1,732
Change	-	92.58%	5.42%	257.85%	-23.73%	-36.8%
Enterprise Value (EV) ¹	566.5	978.9	1,036	3,181	2,466	2,152
Change	-	72.81%	5.79%	207.16%	-22.47%	-12.74%
P/E	12.3x	24.3x	16.7x	26x	15.4x	8.26x
PBR	1.25x	2.17x	1.23x	2.11x	1.47x	0.78x
PEG	-	-8.74x	1.94x	0.3x	0.5x	0.8x
Capitalization / Revenue	0.82x	1.56x	1.53x	4.14x	1.99x	1x
EV / Revenue	0.94x	1.6x	1.58x	3.67x	1.79x	1.25x
EV / EBITDA	8.03x	17.9x	20.8x	18.3x	14.5x	9.55x
EV / EBIT	9.18x	20.9x	25.6x	21.2x	16.4x	10.8x
EV / FCF	-20.6x	32.8x	-5.89x	-6.22x	-9.86x	-1.65x
FCF Yield	-4.86%	3.05%	-17%	-16.1%	-10.1%	-60.4%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	0.319	0.3101	0.3369	0.608	0.783	0.8635
Distribution rate	-	-	-	-	-	-
Net sales ¹	600.4	612.1	656	867.1	1,379	1,727
EBITDA ¹	70.53	54.76	49.7	173.9	170.4	225.4
EBIT ¹	61.72	46.88	40.51	150.2	150.5	198.9
Net income ¹	40.38	39.23	49.21	131.8	181.2	209.8
Net Debt ¹	71.83	26.33	31.28	-412.9	-274.8	419.5
Reference price ²	3.91	7.53	5.61	15.80	12.05	7.13
Nbr of stocks (in thousands)	126,503	126,503	179,010	227,448	227,448	242,948
Announcement Date	9/8/21	9/9/22	9/9/23	9/7/24	9/8/25	9/8/26

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GENNEX LABORATORIES LIMITED	-	-	-	-	25.6M
ELI LILLY AND COMPANY	33.65x	12.19x	24.78x	0.59%	1,055B
JOHNSON & JOHNSON	30.17x	6.71x	18.78x	1.98%	654B
ABBVIE INC.	33.43x	7.82x	16.17x	2.59%	467B
ROCHE HOLDING AG	19.59x	4.78x	11.84x	2.78%	348B
NOVARTIS AG	20.4x	5.31x	13.17x	3.01%	275B
ASTRAZENECA PLC	21.19x	4.39x	12.5x	2.01%	258B
AMGEN INC.	26.19x	6.82x	12.15x	2.43%	224B
GILEAD SCIENCES, INC.	-45.65x	6.64x	25.94x	2.18%	187B
NOVO NORDISK A/S	11.33x	4.13x	8.58x	4.44%	171B
Average	16.70x	6.53x	15.99x	2.45%	363.84B
Weighted average by Cap.	24.18x	7.87x	18.13x	1.96%